PINE BROOK, N.J.--(BUSINESS WIRE)--Alvogen today announced the launch of the first generic equivalent of Zoladex TM in Central and Eastern Europe. The product will be marketed in two strengths (3.6mg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback